Results 201 to 210 of about 1,059,639 (249)
Some of the next articles are maybe not open access.
Antiarrhythmic Drug Monitoring
Clinics in Laboratory Medicine, 1981The classification of antiarrhythmic agents by mechanism of action aids the clinician in selecting appropriate antiarrhythmic drug therapy. The pharmacokinetics, the side effects, and the interpretation of serum levels of quinidine, procainamide, disopyramide, lidocaine, and other agents are discussed.
J H, Howanitz, P J, Howanitz
openaire +2 more sources
The American Journal of Cardiology, 1989
Clinical failure of antiarrhythmic drugs often occurs in practice. Therefore, there is a need for new, effective and long-acting drugs with a wide therapeutic range and a low level of toxicity. Most new class I compounds block the fast sodium ion inward current of myocardial cells.
P, Jaillon, M, Drici
openaire +2 more sources
Clinical failure of antiarrhythmic drugs often occurs in practice. Therefore, there is a need for new, effective and long-acting drugs with a wide therapeutic range and a low level of toxicity. Most new class I compounds block the fast sodium ion inward current of myocardial cells.
P, Jaillon, M, Drici
openaire +2 more sources
Sulfinpyrazone: An Antiarrhythmic Drug?
Pacing and Clinical Electrophysiology, 1982The patients were studied by intracardiac electrocardiography and programmed stimulation before and after an intravenous bolus injec tion of either 500 mg sulfinpyrazone or a placebo. We found no consistent clinical or statistical effects of sulfinpyrazone on sinus rate, sinus node recovery time, sinoatrial conduction time, conduction intervals during ...
J C, Roos, A J, Dunning
openaire +2 more sources
The American Journal of Surgery, 1983
Great advances have been made in our understanding of cardiac arrhythmias and the effect of drugs on these arrhythmias. Several new types of antiarrhythmic drugs have been introduced. For example, encainide, flecainide, or lorcainide are new type I drugs that exert their major effects on depressing cardiac conduction.
M M, Scheinman, D S, Hess
openaire +2 more sources
Great advances have been made in our understanding of cardiac arrhythmias and the effect of drugs on these arrhythmias. Several new types of antiarrhythmic drugs have been introduced. For example, encainide, flecainide, or lorcainide are new type I drugs that exert their major effects on depressing cardiac conduction.
M M, Scheinman, D S, Hess
openaire +2 more sources
Drugs, 1988
While controversy still exists as to the precise indications for the treatment of all forms of ventricular arrhythmia, advances in the number and, more importantly, type of antiarrhythmic drugs can provide the clinician with a rational basis for selecting antiarrhythmic drug therapy.
P F, Nestico +2 more
openaire +2 more sources
While controversy still exists as to the precise indications for the treatment of all forms of ventricular arrhythmia, advances in the number and, more importantly, type of antiarrhythmic drugs can provide the clinician with a rational basis for selecting antiarrhythmic drug therapy.
P F, Nestico +2 more
openaire +2 more sources
Medical Clinics of North America, 1988
The effective management of cardiac arrhythmias remains a major challenge in cardiovascular therapeutics. The management of arrhythmias encompasses a wide spectrum of supraventricular and ventricular tachyarrhythmias occurring in patients with various cardiac diagnoses and different degrees of myocardial dysfunction.
E L, Michelson, L S, Dreifus
openaire +2 more sources
The effective management of cardiac arrhythmias remains a major challenge in cardiovascular therapeutics. The management of arrhythmias encompasses a wide spectrum of supraventricular and ventricular tachyarrhythmias occurring in patients with various cardiac diagnoses and different degrees of myocardial dysfunction.
E L, Michelson, L S, Dreifus
openaire +2 more sources
The Journal of Clinical Pharmacology, 1989
Discussion sur l'efficacite d'un traitement antiarrythmique apres un infarctus du myocarde, sur la diminution de la mortalite chez les malades. Difficulte pratique d'effectuer un essai avec la flecainide et l'encainide, due a la mauvaise information des ...
openaire +2 more sources
Discussion sur l'efficacite d'un traitement antiarrythmique apres un infarctus du myocarde, sur la diminution de la mortalite chez les malades. Difficulte pratique d'effectuer un essai avec la flecainide et l'encainide, due a la mauvaise information des ...
openaire +2 more sources
Antiarrhythmic drugs: Past, present and future
Heart Rhythm, 2003When the North American Society of Pacing and Electrophysiology (NASPE) was founded 25 years ago, treatments were empiric and targeted diseases or symptoms whose underlying mechanisms were poorly understood, if at all. Therapies available and widely used for arrhythmias in the late 1970s included pacemakers, external defibrillation for cardiac arrest ...
openaire +4 more sources